Fundamentals of Bioengineering (BIOE252)
Conservation Principles in Bioengineering - Textbook Preview
Chapter 1 - Introduction to Engineering Calculations | Chapter 2 - Foundations of Conservation Principles |
Chapter 3 - Conservation of Mass | Chapter 4 - Conservation of Energy |
Chapter 5 - Conservation of Charge | Chapter 6 - Conservation of Momentum | Chapter 7 - Case Studies



Chapter 3 - Conservation of Mass

 

OVERVIEW

 

Conservation of mass is the topic of Chapter 3.  The challenge problem is tissue engineering and its application for bone enhancement and replacement;  worked example problems include flow through a bone graft, oxygen consumption in bone, and toxin accumulation in a laboratory bone implant.  The principles of mass balances are illustrated first for open, non-reacting, steady-state systems.  Systems with multiple inlets and outlets and then systems with multicomponent mixtures are considered.  More complex multiple-unit systems are illustrated by a two-compartment model of the kidney and by a wastewater treatment facility.  Systems with chemical reactions, such as respiration, are explicitly covered.  Terms such as reaction rate and fractional conversion are defined.  Finally, dynamic systems such as drug delivery are addressed. 

 

 

EXAMPLE PROBLEMS

 

1.  The drug streptomycin is produced on a large scale in the U.S.  After purification, streptomycin is 50 wt% in water.  For applications, including I.V. drips, the streptomycin must be diluted and preservative must be added.  The diluent stream contains 2 wt% NaCl in water.  The preservative stream contains 10 wt% preservative and 5 wt% NaCl in water.  These three streams are mixed together in a mixing tank.  The outlet stream is ready for packaging in I.V. bags. 

 

a.      Determine the ratio of the stream containing the drug to the outlet stream given that the drug is 10 wt% in the outlet stream.

 

b.     Determine the ratio of the stream containing the preservative to the outlet stream given that the preservative is 3 wt% in the outlet stream.

 

c.      Determine the ratio of the diluent stream to the outlet stream given that the drug is 10 wt% and the preservative is 3 wt% in the outlet stream.  (You answer may include an unknown variable.)

 

2.   During cellular metabolism, glucose is combusted to carbon dioxide and water.  One of the many steps in glycolysis is the Kreb’s cycle.  A biochemical summary of several steps in the Kreb’s cycle is as follows:

 

      1 C6H8O7 (citric acid) + a H2O à p C4H4O5 (oxaloacetic acid) + q H + r CO2

 

      It is known through biochemical experiments that for every molecule of citric acid consumed, one molecule of oxaloacetic acid is generated. 

 

a.      Balance the above equation.  Determine the stoichiometric coefficients a, p, q, and r.

 

A tissue mass is comprised of many cells, each which conducts the process of glycolysis including the Kreb’s cycle.  Assume a molar flow rate of 0.1 mol/day of C6H8O7 into this tissue.

 

b.     What is the minimum flow rate of water needed for a fractional conversion of the C6H8O7 to be 1.0?

 

c.      Assume that the fractional conversion of water is 0.8 and the fractional conversion of C6H8O7 is 1.0.  What is the limiting reactant?  Calculate the reaction rate (R) and the inlet molar flow rate of H2O.  Determine the molar flow rates of the products and the excess reactant leaving the tissue.

 

3.  Biodegradable synthetic materials are now being explored for use as carriers for drug delivery.  Poly(lactic-co-glycolic) acid (PLGA) is one such material currently being explored for this purpose as it is already approved by the FDA for use in the human body.  Microspheres loaded with drug can be fabricated.  By varying the properties of the polymer comprising the microsphere, the release profile of the drug can be altered systematically.

 

      You have run an experiment to determine the effects of microsphere diameter on the release of the model drug, FITC-BSA (fluorescently-labeled bovine serum albumin).  The release curve for spheres (diameter = 30 mm) is shown in Fig. 3P.12.  After fitting a curve to your data, you find that the release of FITC-BSA can be modeled as follows:

                       

 

      Initially, the mass of the model drug FITC-BSA in the microsphere is 1 mg.  Determine the amount of drug released after 30 days.

Chapter 2 - Foundations of Conservation Principles | Chapter 4 - Conservation of Energy